{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["15"],"submitter":["Martinez-Atienza J"],"pubmed_abstract":["<h4>Background</h4>Despite administration of annual influenza vaccination, influenza-associated complications in transplant recipients continue to be an important cause of hospitalization and death. Although influenza vaccination has been proven to be the most effective measure to reduce influenza infection after transplantation, transplant recipients are still vulnerable to influenza infections, with lower serological responses to vaccination compared to the general population. In order to assess the efficacy and safety of an alternative immunization scheme for solid organ transplant recipients, the TRANSGRIPE1-2 Study Group aimed to test a booster dose administration 5 weeks after the standard vaccination. The primary objective of this trial was to compare short-term and long-term neutra"],"journal":["Trials"],"pagination":["338"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC4159520"],"repository":["biostudies-literature"],"pubmed_title":["Efficacy and safety of a booster dose of influenza vaccination in solid organ transplant recipients, TRANSGRIPE 1-2: study protocol for a multicenter, randomized, controlled clinical trial."],"pmcid":["PMC4159520"],"pubmed_authors":["Barcena Marugan R","Busto Sorroche B","Ferrer A","Galvez Acebal J","de la Torre Cisneros J","Rodriguez Ferrero ML","Revilla A","Gash Illescas A","Niubo Bosch J","Bulnes Ramos A","Gomez Bravo MA","Suarez Benjumea A","Lage Calle E","Munoz Garcia P","Fernandez Navarro A","Munoz P","Gutierrez B","Morales Barroso I","Sanchez Aguera M","Bodro Marimont M","Sota Busselo M","Cordero Matia E","Cofran F","Gonzalez E","Aguilar Jimenez M","Suarez-Benjumea A","Blanes Julia M","Sabe N","Angeles Marcos M","Marcen Letosa R","TRANSGRIPE 1-2 Study Group","Casafont Morencos F","Rosso-Fernandez C","Urcelay Lopez MI","Piqueras R","Benito Zazo N","Duran Calvo MR","Torre-Cisneros J","Paez Vega A","Gentil MA","Bustinza Txertudi A","Fernandez Rozas S","Perez-Romero P","Molero Fornieles L","Cervera Alvarez C","Moreno A","Delgado JF","Carriba Rodriguez J","Coya Guerrero R","Allende Aydillo T","Lopez Roa P","Roca Elias J","Perez Villa F","Hoyo Ulloa I","Bayas JM","Diez Herran N","Roca Oporto C","Gonzalez Costello J","Fortun J","Arminanzas Castillo C","Abad OL","Cordero E","Martin Davila P","Sousa JM","Baliellas Comellas C","Fortun Abete J","Llado Garriga L","Aydillo TA","Barranco JL","Gonzalez Rico C","Farinas MC","Nebot Margalef M","Pahissa Berga A","Tordera M","Ruiz AL","Zurbano Goni F","Contreras RL","Cabrero Martinez I","Salavert Lleti M","Rosso Fernandez C","Lopez-Medrano F","Fabregas Garcia E","Bernal Blanco G","Perez  Romero P","Puerta Cruz C","Fernandez Gil R","Garcia L","Martinez L","Martinez Atienza J","Rodriguez Hernandez MJ","Hernandez JM","Salcedo M","Carratala J","Gomez Castilla C","Farinas M","Molina Ortega FJ","Alamo JM","Garcia Cubiles L","Catalan P","Peguin M","Perez Romero P","Lopez Aldeguer J","Gavalda J","Casasnovas YS","Moreno Camacho A","Martinez-Atienza J","Gavalda Sant Pau J","Roca C","Cobo Belaustegui M","Martinez Rienda MI","Roman Broto A","Morales JM","Madrid Elena N","Blanes-Julia M","Montejo JM","Valerio Minero M","Colmenero Arroyo J","Sanclemente Juarros G","Cuellar Tovar S","Rosso Fernandez CM"],"additional_accession":[]},"is_claimable":false,"name":"Efficacy and safety of a booster dose of influenza vaccination in solid organ transplant recipients, TRANSGRIPE 1-2: study protocol for a multicenter, randomized, controlled clinical trial.","description":"<h4>Background</h4>Despite administration of annual influenza vaccination, influenza-associated complications in transplant recipients continue to be an important cause of hospitalization and death. Although influenza vaccination has been proven to be the most effective measure to reduce influenza infection after transplantation, transplant recipients are still vulnerable to influenza infections, with lower serological responses to vaccination compared to the general population. In order to assess the efficacy and safety of an alternative immunization scheme for solid organ transplant recipients, the TRANSGRIPE1-2 Study Group aimed to test a booster dose administration 5 weeks after the standard vaccination. The primary objective of this trial was to compare short-term and long-term neutra","dates":{"release":"2014-01-01T00:00:00Z","publication":"2014 Aug","modification":"2025-06-01T03:56:49.66Z","creation":"2019-03-27T01:35:28Z"},"accession":"S-EPMC4159520","cross_references":{"pubmed":["25168918"],"doi":["10.1186/1745-6215-15-338"]}}